Cargando…

EHMTI-0031. Efficacy and safety of venlafaxine for the treatment of chronic migraine: a randomized, double-blind, controlled trial

Detalles Bibliográficos
Autores principales:	Togha, M, Taghdiri, F, Jahromi, S Razeghi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181988/ http://dx.doi.org/10.1186/1129-2377-15-S1-G38

Ejemplares similares

EHMTI-0292. The effect of body fat mass and fat free mass on migraine headache
por: jahromi, S Razeghi, et al.
Publicado: (2014)

EHMTI-0293. Comparison between celecoxib and prednisolone in bridge stage therapy following medication overuse headache: double blind randomized clinical trial
por: Togha, M, et al.
Publicado: (2014)

Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study
por: Taghdiri, Foad, et al.
Publicado: (2014)

EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study
por: Goadsby, P, et al.
Publicado: (2014)

EHMTI-0146. Topiramate in migraine prevention
por: Ristic, S, et al.
Publicado: (2014)

EHMTI-0358. Improved chronic migraine after DTMS
por: Scatena, P, et al.
Publicado: (2014)

EHMTI-0222. Habituation of visual evoked potentials in migraine: comparison between blinded and non-blinded analyses
por: Ambrosini, A, et al.
Publicado: (2014)

EHMTI-0039. Different efficacy of acute migraine therapies for migraine with aura versus without aura
por: Hansen, J Møller, et al.
Publicado: (2014)

EHMTI-0108. Efficacy of therapy in patients with migraine: comparison in group of < 9 migraines and > 10 migraines per month
por: Cvetkovic, V Vukovic, et al.
Publicado: (2014)

EHMTI-0086. Pure mestrual vestibular migraine
por: Mostardini, C, et al.
Publicado: (2014)

EHMTI-0049. Headache, migraine and epileptic seizures
por: Gligic, N, et al.
Publicado: (2014)

EHMTI-0089. Relationship of sleep bruxism and migraine
por: Kato, M, et al.
Publicado: (2014)

EHMTI-0249. Headache attributed to hypertension in chronic migraine patients
por: Grosu, O, et al.
Publicado: (2014)

EHMTI-0037. Botulinum A toxin for treatment of chronic migraine
por: Grazzi, L, et al.
Publicado: (2014)

EHMTI-0105. CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine
por: Cernuda-Morollón, E, et al.
Publicado: (2014)

EHMTI-0334. Chronic migraine in young age: clinical characteristics in a prospective chronic migraine registry
por: Ruiz, M, et al.
Publicado: (2014)

EHMTI-0111. Intra-variability of migraine attacks features
por: Viana, M, et al.
Publicado: (2014)

EHMTI-0122. Serum micrornas as potential biomarkers of migraine
por: Andersen, HH, et al.
Publicado: (2014)

EHMTI-0107. Treatment of migraine in Croatia, year 2013
por: Cvetkovic, V Vukovic, et al.
Publicado: (2014)

EHMTI-0348. Refractive errors in patients with migraine headache
por: Gunes, A, et al.
Publicado: (2014)

EHMTI-0050. Systemic and cerebral endothelial function in migraine
por: Zaletel, M, et al.
Publicado: (2014)

EHMTI-0189. Tryptophan-kynurenine metabolism in migraine patients
por: Majláth, Z, et al.
Publicado: (2014)

EHMTI-0070. Effect of occlusal sprint in migraine patients
por: Takeuchi, M, et al.
Publicado: (2014)

EHMTI-0374. Gene-based pleiotropy across migraine with and migraine without aura
por: Nyholt, D, et al.
Publicado: (2014)

EHMTI-0230. Characteristics of menstrual and nonmenstrual migraine attacks in women with menstrual migraine
por: Vetvik, KG, et al.
Publicado: (2014)

EHMTI-0202. Study protocol of BoTN: a randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of botulinum toxin injections in the treatment of trigeminal neuralgia
por: Burmeister, J, et al.
Publicado: (2014)

B vitamins and their combination could reduce migraine headaches: A randomized double-blind controlled trial
por: Nematgorgani, Shiva, et al.
Publicado: (2022)

EHMTI-0319. TMS-measured cortical excitability do not change by migraine phase: a blinded longitudinal study
por: Uglem, M, et al.
Publicado: (2014)

EHMTI-0283. Predictors of early response to onabotulinumtoxin type a in chronic migraine
por: Mas-Sala, N, et al.
Publicado: (2014)

EHMTI-0394. Predictive parameters for the effect of botulinum toxin infiltrations in chronic migraine
por: Bergmans, BA, et al.
Publicado: (2014)

EHMTI-0026. Neuroprolotherapy and acupuncture for clinical trial of acute and chronic migraine treatment
por: Schulman, R
Publicado: (2014)

EHMTI-0080. How migraine is affected by therapies for multiple sclerosis
por: Condello, C, et al.
Publicado: (2014)

EHMTI-0030. Migraine pain location in adult: the bangladeshi experience
por: Haque, R
Publicado: (2014)

EHMTI-0194. The impact of dizziness in tertiary care migraine patients
por: Sugrue, J, et al.
Publicado: (2014)

EHMTI-0044. Variability of clinical features in attacks of migraine with aura
por: Hansen, J Møller, et al.
Publicado: (2014)

EHMTI-0055. Abnormal thalamic function in patients with vestibular migraine
por: Russo, A, et al.
Publicado: (2014)

EHMTI-0206. Nigerian plants that are used for treatment of headache and migraine
por: Saganuwan, SA
Publicado: (2014)

EHMTI-0313. Factors influencing stigma towards persons with migraine
por: Shapiro, RE, et al.
Publicado: (2014)

EHMTI-0377. The influence of genetic constitution on migraine drug responses
por: Christensen, AF, et al.
Publicado: (2014)

EHMTI-0360. Chronic sympathetic activation in migraine headache: unique to migraine or common to sympathetic nervous system disorders?
por: Thomas, MR
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oo5ogqgeaupujncfojc3b4hd3d